CRL Charles River
- 233.470
- +3.580+1.56%
- 233.398
- -0.072-0.03%
Charles River News
Goldman's Top 50 Stable Growth Stocks
Earnings Flash (CRAI) CHARLES RIVER ASSOCIATES Reports Q1 EPS $1.96, Vs. Street Est of $1.40
08:06 AM EDT, 05/02/2024 (MT Newswires) -- Earnings Flash (CRAI) CHARLES RIVER ASSOCIATES Reports Q1 EPS $1.96, vs. Street Est of $1.40
Express News | Charles River Associates (CRA) Reports Financial Results for the First Quarter of 2024
Express News | Charles River Launches Viral Vector Reference Materials to Streamline the Transition to Gmp
Charles River Associates (CRA) Declares Quarterly Cash Dividend of $0.42 Per Common Share
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced that its Board of Directors ha
It's Unlikely That Charles River Laboratories International, Inc.'s (NYSE:CRL) CEO Will See A Huge Pay Rise This Year
Key Insights Charles River Laboratories International to hold its Annual General Meeting on 8th of May Total pay for CEO Jim Foster includes US$1.46m salary The overall pay is 52% above the indust
Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Charles River Labs (CRL) and Neurocrine (NBIX)
Neptune Flood Acquires Data Science Firm Charles River Data to Enhance AI-Driven Flood Insurance Solutions
ST. PETERSBURG, Fla., May 1, 2024 /PRNewswire/ -- Neptune Flood, the nation's largest private flood insurance company, today announced its acquisition of Charles River Data, a renowned Boston-based d
Charles River Associates (CRA) Strengthens Its Antitrust & Competition Economics Practice
Dr. Svend Albæk, Former Deputy Chief Economist in European Commission's Directorate-General for Competition, Joins CRA as Senior Consultant Charles River Associates (NASDAQ:CRAI), a worldwide leader in providing
The "highest Quality" Stocks Within Each Sector - GS
Iterum Therapeutics Resubmits New Drug Application to U.S. FDA for Oral Sulopenem
With Rate Cuts Pushed Out, Goldman Looks at Quality Stocks
Investors are looking to quality stocks amid the prospect of delayed Fed rate cuts.
Charles River Laboratories International, Inc.'s (NYSE:CRL) Price Is Out Of Tune With Earnings
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 16x, you may consider Charles River Laboratories International, Inc. (NYSE:CRL) as a stock to potentially avoid with its 24.8x P/E ratio.
FibroBiologics, Charles River Laboratories Sign Letter Of Intent Allowing For Transfer, Testing And Validation Of Technology
This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of FibroBiologics' master cell bank, working cell bank, and fibroblast-based sp
Express News | Fibrobiologics Plans to Collaborate With Charles River to Manufacture Fibroblast-Based Spheroids
Express News | Charles River Shares Are Trading Higher in Possible Sympathy With Danaher, Which Reported Better-than-expected Q1 Financial Results
Charles River Associates (CRA) to Host First-Quarter Fiscal 2024 Financial Results Conference Call on May 2
Conference Call to be Webcast Live at 10:00 a.m. ET Charles River Associates (NASDAQ:CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that the company
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
Company marks significant progress towards climate goals, reaching the milestone considerably ahead of scheduleWILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #LIFEatCRL--Charles River Laboratories Internati
Here's Why You Should Retain Charles River (CRL) Stock Now
Express News | Charles River Laboratories International - Initiative Focuses on Innovation, Partnerships, Advocacy as Part of $500 Mln Investment in Driving Change
Analysis
Price Target
No Data
